CRISPR Therapeutics AGCRSPNASDAQ
Loading
Cash generated from core business operations
Latest
$-345.01M
↓ 211% vs avg
Percentile
P9
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-110.83M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-345.01M | -141.7% |
| 2024 | $-142.77M | +45.2% |
| 2023 | $-260.38M | +47.5% |
| 2022 | $-495.74M | -192.0% |
| 2021 | $538.97M | +326.1% |
| 2020 | $-238.37M | -520.6% |
| 2019 | $56.68M | +158.9% |
| 2018 | $-96.24M | -37.3% |
| 2017 | $-70.10M | -26.7% |
| 2016 | $-55.31M | - |